ClinicalTrials.gg
CompletedNCT03273803Updated Oct 30, 2026

Cardiac Auscultation Using Smartphones

An observational study in Cardiovascular Physiological Phenomena, sponsored by Seoul National University Hospital. Completed at 1 site in South Korea. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Seoul National University Hospital · Observational

Updated Oct 30, 2026First site in South KoreaNo longer in Korea, Republic of+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
46
Ages
18 Years and older
Sex
All
01

Study summary

The investigators performed a proof-of-concept study enrolling subjects with normal and pathologic heart sounds. Heart sound was recorded by auscultation on the skin of the chest wall using three smartphones: Samsung Galaxy S5 and Galaxy S6, and LG G3 . Recorded heart sounds were processed and classified by a diagnostic algorithm using convolutional neural networks.

Read the detailed description

Heart sound recording was done by researchers who were familiar with the use of the app and understand the principles of cardiac auscultation.

Reference heart sounds were recorded using an electronic stethoscope (3M™ Littmann® Electronic Stethoscope Model 3200). Study devices included Samsung Galaxy S5 (model SM-G900), Galaxy S6 (SM-G920), and LG G3 (LG-F400).

02

Conditions studied

  • Cardiovascular Physiological Phenomena

Keywords

  • Heart sounds, smartphone, application
03

In context

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,900 studies on the registry; 274 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Men and women were evenly enrolled, and the median age was 65.5 years.

Twenty subjects (43.5%) had systolic murmur, 20 (43.5%) normal heart sound, 5 (10.9%) diastolic murmur, and 1 (2.2%) S4.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • subjects who gave
  • subjects who are 18 years old or older and had performed and echocardiography during the previous 6 months.

Exclusion criteria

Exclusion Criteria:

  • subjects with impairment of cognition
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
46 participants (actual)
Patient registry
No

Interventions

  • Diagnostic testHeart sound recording using smartphone application

    Heart sound recording and analysis using android smartphones (Samsung Galaxy S5, Galaxy S6, and LG G3)

06

What researchers measure

Primary outcomes

  1. Accuracy of "CPstethoscope" in interpretation of heart sounds

    specificity, sensitivity, negative predictive value, positive predictive value

    Time frame: 0

07

Study locations

1 site
  • Seoul National University Bundang Hospital
    Seongnam-si, Gyeonggi-do 463707, South Korea
08

References and documents

Publications

  • Kang SH, Joe B, Yoon Y, Cho GY, Shin I, Suh JW. Cardiac Auscultation Using Smartphones: Pilot Study. JMIR Mhealth Uhealth. 2018 Feb 28;6(2):e49. doi: 10.2196/mhealth.8946. PubMed 29490899 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2016 to primary completion in Oct 2016, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 3, 2017
First posted
Sep 6, 2017
StartActual
Aug 24, 2016
Primary completionActual
Oct 31, 2016
CompletionActual
Jun 8, 2017
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed — first site in South Korea; no longer in Korea, Republic of
Show site
  • Seoul National University Bundang Hospital · Seongnam-si, South Korea
Show 1 removed
  • Seoul National University Bundang Hospital · Seongnam, Korea, Republic of
Oct 30, 2026
Eligibility
Minimum age none→18 Years; Sex none→ALL
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    1 site added, 1 site removed — first site in South Korea; no longer in Korea, Republic of
    Show site
    • Seoul National University Bundang Hospital · Seongnam-si, South Korea
    Show 1 removed
    • Seoul National University Bundang Hospital · Seongnam, Korea, Republic of
    Eligibility Minimum age none→18 Years; Sex none→ALL
    + 2 other changes: verification date and references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT03273803
Collaborators
Korea Advanced Institute of Science and Technology
Responsible party
Jung-Won Suh (MD, PhD, Seoul National University Hospital) — Principal investigator
First posted
Sep 6, 2017
Start date
Aug 24, 2016
Primary completion
Oct 31, 2016
Completion
Jun 8, 2017
Last update
Oct 30, 2026

Study contacts

Jung-Won Suh, MD, PhD
principal investigator · Seoul National University Bundang Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion